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Summary
Objective: To investigate the single and combined effects of electromagnetic ﬁeld (EMF) exposure and the insulin growth factor-I (IGF-I) on
proteoglycan (PG) synthesis of bovine articular cartilage explants and chondrocytes cultured in monolayers.
Design: Bovine articular cartilage explants and chondrocyte monolayers were exposed to EMF (75 Hz; 1.5 mT) for 24 h in the absence and in
the presence of both 10% fetal bovine serum (FBS) and IGF-I (1e100 ng/ml). PG synthesis was determined by Na2e
35SO4 incorporation. PG
release into culture medium was determined by the dimethylmethylene blue (DMMB) assay.
Results: In cartilage explants, EMF signiﬁcantly increased 35S-sulfate incorporation both in the absence and in the presence of 10% FBS.
Similarly, IGF-I increased 35S-sulfate incorporation in a dose-dependent manner both in 0% and 10% FBS. At all doses of IGF-I, the combined
effects of the two stimuli resulted additive. No effect was observed on medium PG release. Also in chondrocyte monolayers, IGF-I stimulated
35S-sulfate incorporation in a dose-dependent manner, both in 0% and 10% FBS, however, this was not modiﬁed by EMF exposure.
Conclusions: The results of this study show that EMF can act in concert with IGF-I in stimulating PG synthesis in bovine articular cartilage
explants. As this effect is not maintained in chondrocyte monolayers, the native cellematrix interactions in the tissue may be fundamental in
driving the EMF effects. These data suggest that in vivo the combination of both EMF and IGF may exert a more chondroprotective effect than
either treatment alone on articular cartilage.
ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Cartilage
Repair
SocietyIntroduction
The mechanical and functional properties of articular
cartilage depend on the complex composition and organi-
zation of its extracellular matrix (ECM). The synthesis and
degradation of ECM components is strictly regulated by
articular chondrocytes, which maintain cartilage homeosta-
sis in normal conditions. In pathological conditions, such as
osteoarthritis (OA) and rheumatoid arthritis (RA), alterations
in the normal functional activities of chondrocytes contribute
to the imbalance in turnover of ECM components with
degradation exceeding synthesis1,2 resulting in gradual
damage of the articular cartilage. The anabolic and
catabolic activities of chondrocytes are controlled by
several biochemical factors including growth factors,
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Received 18 December 2003; revision accepted 18 June 2004.79cytokines and hormones3e5. The insulin-like growth factor-
I (IGF-I), present in both synovial ﬂuid6 and articular
cartilage7, plays a key role among the anabolic growth
factors which control articular chondrocyte metabolism.
IGF-I stimulates chondrocyte proliferation and the synthesis
of type II collagen and proteoglycans (PGs), the major
components of the articular cartilage ECM8e14. In addition,
several studies show that declining IGF-I sensitivity is
associated with the age-related loss of synthetic activities in
chondrocytes and that impaired IGF-I response is charac-
teristic of OA cartilage15e17.
Articular chondrocyte activities are also affected by
several biophysical forces, including mechanical stresses
and strains14, ultrasounds18 and low-frequency low-energy
electromagnetic ﬁelds (EMFs). Previous in vivo19e21 and
in vitro22,23 studies have shown that EMF exposure may act
as a modulator of cartilage metabolism by stimulating
chondrocyte proliferation and the synthesis of ECM
components. Recently, we have shown that EMF is able
to increase matrix PG synthesis in bovine articular cartilage
explants and to efﬁciently counterbalance the cartilage PG
loss induced by IL-1, a proinﬂammatory cytokine implicated
in the etiology of OA24. On the basis of these data showing
an anabolic role of EMF exposure on articular cartilage, in3
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EMF and IGF-I in regulating synthetic chondrocyte activi-
ties. With this aim, we analyzed the separate and combined
effects of EMF exposure and IGF-I on PG synthesis. It is
known that chondrocyte metabolism, including matrix
component synthesis and responsiveness to stimuli can
vary in different experimental culture models25e27. There-
fore, we also compared the single and combined effects of
EMF and IGF-I in two different experimental models, both
widely used for studying cartilage metabolism: tissue
explants and chondrocyte monolayers. Finally, as it has
been reported that the EMF effects may be dependent on
the presence of serum in the culture medium23,28, the
possible role of serum was investigated.
Material and methods
REAGENTS
Papain, shark chondroitin sulfate (CS), cetylpyridinium
chloride (CPC), 1,9-dimethylmethylene blue, Hoescht dye
33258, methanol, triton X-100, trichloroacetic acid (TCA),
were from SigmaeAldrich S.r.l. (Milan, Italy). Na2e
35SO4
(2.2 mCi/ml) and 3H-thymidine (10 Ci/mmol) were obtained
from Amersham Pharmacia Biotech (Buckinghamshire,
England). Pronase from Streptomyces griseus was from
Calbiochem (Darmstadt, Germany). Collagenase P from
Clostridium histolyticum was from Roche (Indianapolis,
USA). Dulbecco’s modiﬁed Eagle’s/Ham’s F12 (1:1) medium
(DMEM/F12), fetal bovine serum (FBS) and antibiotics for
both explant and chondrocyte monolayer cultures were
obtained from Life Technologies (Paisley, UK). Recombinant
human (rh)IGF-I was purchased from Peprotech (London,
England). Rabbit anti-human collagen type II polyclonal
antibody and goat anti-collagen type I were from Chemicon
International Inc. (Temecula, CA, USA). Ultraystain poly-
valent-HRP immunostaining kit was from Ylem (Rome, Italy).
CARTILAGE EXPLANT CULTURES
Explants of bovine articular cartilage were aseptically
dissected from the metacarpophalangeal joints of 14e18
month-old animals (Limousine breed), as previously de-
scribed24,29. Full-thickness cartilage discs were obtained
from the articular surface using a 4 mm dermal punch
(Stiefel Laboratories, Milan, Italy). Test and control explants
were paired at harvest and originated from adjacent sites on
the joint surface. Four groups of samples (each group from
each site on the joint surface) including control and test
explants were harvested from each animal donor. At least
ﬁve different animals were used. Explant discs (three/well)
were cultured in 0.5 ml culture medium in multiwells (Nunc,
Denmark, 6.6! 6.6 cm, 1.6 cm the diameter of each well).
Independently from the culture conditions during the
experiments (presence or absence of serum in the culture
medium), before EMF exposure and IGF-I treatment, all
explants were allowed to equilibrate in culture for 48 h in
DMEM/F12 supplemented with 10% FBS and antibiotics
(penicillin 100 units/ml, streptomycin 0.1 mg/ml) (complete
medium) and for an additional 48 h in medium without
serum, at 37(C in an atmosphere of 5% CO2.
CHONDROCYTE MONOLAYER CULTURES
Chondrocytes were isolated from bovine cartilage frag-
ments obtained from the weight-bearing region of thearticular surface, according to Pezzetti et al.23. Brieﬂy, the
cartilage was dissected out and cut into small pieces.
Pieces were subjected to a sequential digestion in DMEM/
F12 with pronase for 90 min and collagenase for about
12 h. The resulting cell suspension was ﬁltered to remove
undigested cartilage. Chondrocytes were recovered by
centrifugation, counted and plated at high density
(300,000/well) in complete medium in multiwells (Nunc,
Denmark, 6.6! 6.6 cm, 1.6 cm the diameter of each well).
Only chondrocytes without subculturing were used in the
experiments. Before EMF exposure and IGF-I treatment,
chondrocyte monolayers were maintained in culture, as
described above for cartilage explants.
IMMUNOHISTOCHEMISTRY FOR TYPE II
AND TYPE I COLLAGEN
The expression of type II and type I collagen in the
chondrocyte monolayer cultures, used in the EMF and IGF-I
treatment experiments, was evaluated by immunohisto-
chemistry. Chondrocyte monolayers were ﬁxed with cold
methanol for 5 min at room temperature, permeabilized with
0.1% Triton X-100 in phosphate-buffered saline for 2 min
and then treated with 3% hydrogen peroxide for 10 min. The
ﬁxed monolayers were rinsed and incubated overnight at
4(C with 1:10 anti-type II collagen and 1:10 anti-type I
collagen antibodies. Stain was obtained by developing with
Ultraystain polyvalent-HRP immunostaining kit, using the
procedure recommended by the manufacturer. Nuclei were
counterstained by hematoxylin. Negative controls were
prepared without primary antibody.
CHARACTERISTICS OF EMF AND TREATMENT CONDITIONS
The EMF generator system was the same used in
previous studies23,24,28 (Igea, Carpi, Italy). The magnetic
ﬁeld was generated by a pair of circular coils of copper wire
placed opposite each other. The coils were powered by the
generator system, which produced the input voltage of
pulse. The pulse duration of the signal was 1.3 ms and
the repetition rate was 75 Hz, yielding a duty cycle of 1/10.
The intensity peak of the magnetic ﬁeld was 1.5 mT and the
induced electric ﬁeld, as detected with a standard coil probe
(50 turns, 0.5 cm internal diameter of the coil probe, 0.2
copper diameter), was 0.07 mV/cm. The intensity of the
magnetic ﬁeld was detected between two coils from one
side to the other, by the Hall probe of the Gaussmeter (LE,
Gaussmeter DG500, USA), with a reading sensitivity of
0.2%. Inside this area, the magnetic ﬁeld was uniform and
was focused on the multiwell, which was placed between
the two coils. The maximum variation of the EMF intensity,
inside each well, was 1%. Taking into account the size of
each well and its position with respect to the magnetic ﬂux
lines, the induced electric ﬁeld inside each well was in
a plane parallel to the multiwell plate surface. In previous
studies, we have shown that 24 h continuous exposure can
stimulate cell proliferation in human chondrocyte mono-
layers23 and PG synthesis in bovine cartilage explants24.
On the basis of these data, both cartilage explants and
monolayer cultures were exposed to EMF for 24 h.
Exposure was performed both in the absence and in the
presence of 10% FBS in the culture medium (0.5 ml/well).
To investigate the effects of EMF in the presence of IGF-I,
increasing doses of IGF-I (1, 5, 10, 50, 100 ng/ml) were
added to the culture medium. In the text, explants and
monolayers cultured in the absence of both EMF exposure
and IGF-I are indicated as controls. Medium was changed
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were placed inside the same incubator at a distance where
no difference from background magnetic ﬁeld was ob-
served, when the EMF generator was turned on. All
treatments were performed with triplicate wells.
QUANTIFICATION OF PG SYNTHESIS
During the 24 h of EMF exposure, 5 mCi/ml of Na2e
35SO4
was added to the culture media. After the radiolabeling,
both explants and monolayers were rinsed and digested in
20 mM phosphate buffer (pH 6.8) containing 4 mg/ml
papain at 60(C for 12 h30. The content of 35S-labeled
newly synthesized PGs (35S-PGs) was measured following
precipitation of the 35S-PGs with CPC31 and ﬁltration onto
glass ﬁber ﬁlters (Whatman GF/C). Filters were dried and
radioactivity was quantitated by liquid scintillation counting.
Results were expressed as cpm/mg DNA.
QUANTIFICATION OF MEDIUM PG RELEASE
PG release into culture media was determined as total
sulfated glycosaminoglycans (sGAG) using the dimethyl-
methylene blue (DMMB) assay, with shark CS as the
standard32.
TOTAL DEOXYRIBONUCLEIC ACID DETERMINATION
Aliquots from both cartilage explants and chondrocyte
monolayers papain-digests were analyzed for DNA content
by the ﬂuorometric method of Labarca and Paigen33.
3H-THYMIDINE INCORPORATION
In some experiments, the effects of EMF exposure and
IGF-I (100 ng/ml) on 3H-thymidine incorporation were
evaluated. Brieﬂy, both for cartilage explants and chondro-
cyte monolayers, 1 mCi/well of 3H-thymidine was added to
the culture media during the 24 h of culture. 3H-thymidine
incorporation was measured in papain-digests by TCA
precipitation and ﬁltration onto glass ﬁber ﬁlters (Whatman
GF/C), as previously described23. 3H-thymidine incorpora-
tion values were normalized to corresponding control levels.
STATISTICAL ANALYSIS
Data obtained from at least ﬁve animals were used in the
study. From each animal, four groups of samples, each
group including control and test samples, were obtained.
Therefore in the statistical analysis, at least 20 cultures for
both control and each treatment group were analyzed.
All values are expressed as meanG standard deviation
for each experimental group. The analysis of variance
(ANOVA) test showed that no signiﬁcant differences could
be observed in the mean values and in the standard
deviations among specimens obtained by different animals,
both in the control group and in the treatment groups; for
this reason all data obtained by the experiments have been
considered together in the analysis.
In order to study the effect of IGF-I on cartilage in the
presence or absence of 10% FBS, we used ANOVA test to
compare control group (in the absence of IGF-I) with groups
treated with different doses of IGF-I. When the ANOVA test
indicated that the model was signiﬁcant, post hoc compar-
isons were performed to determine differences between
control group and each single IGF-I group using unpairedDunnett’s test (P! 0.05). The effect of EMF on cartilage
was also tested separately at each concentration of IGF-I
and in the presence or the absence of 10% FBS by Student
t test (unpaired, two tails). Student unpaired t test (two tails)
was used to investigate dose-dependent effects between
0 ng/ml and 100 ng/ml concentration of IGF-I. Statistical
signiﬁcance was obtained when at least P! 0.05. All
statistical analyses were performed with SPSS 9.0 software
(SPSS Inc., MA, USA).
Results
EFFECTS OF EMF EXPOSURE AND IGF-I ON PG SYNTHESIS OF
CARTILAGE EXPLANTS
The effects of EMF exposure and IGF-I treatment on PG
synthesis, monitored as 35S-sulfate incorporation, observed
in cartilage explants in the absence and in the presence of
10% FBS, are summarized in Figs. 1 and 2, respectively. In
the absence of both serum and IGF-I treatment, EMF
exposure alone induced a 20% increase in 35S-sulfate
incorporation, as compared with controls. According to its
well-established anabolic properties8,9,12e14, IGF-I induced
a signiﬁcant increase in 35S-sulfate incorporation ranging
from 26% at the dose of 10 ng/ml, to 45% at the dose of
100 ng/ml; whereas it did not affect 35S-sulfate incorpora-
tion at the lower doses. At all the doses of IGF-I, when IGF-
I-treated explants were exposed to EMF, 35S-sulfate
incorporation resulted signiﬁcantly higher than in explants
treated with the respective dose of IGF-I alone. Indepen-
dently of the growth factor concentration, the EMF-induced
increase in 35S-sulfate incorporation resulted additive to the
IGF-I-induced increase.
Similar results were obtained in cartilage explants treated
in the presence of 10% FBS, with only slight differences
with respect to explants treated in the absence of serum.
Control explants, cultured in medium containing 10% FBS
showed a basal higher 35S-sulfate incorporation than
control explants cultured in medium in the absence of
serum. In the presence of 10% FBS, IGF-I induced
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Fig. 1. Effects of IGF-I and EMF on PG synthesis. Bovine cartilage
explants, cultured in 0% FBS, were treated for 24 h with increasing
doses of IGF-I (1, 5, 10, 50, 100 ng/ml) in the absence (,) or
presence ( ) of EMF. All data are expressed as meansG S.D.
Percentage changes relative to control (explants cultured in the
absence of both EMF exposure and IGF-I) are shown. Differences
were considered signiﬁcant at P% 0.05. ( indicates statistical
signiﬁcance vs control. * indicates statistical signiﬁcance vs the
same dose of IGF-I without EMF exposure. # indicates statistical
signiﬁcance vs the previous dose of IGF-I.
796 M. De Mattei et al.: Effects of EMF and IGF-I in bovine articular cartilagea signiﬁcant increase in 35S-sulfate incorporation from the
dose of 10 ng/ml (24% over controls), however, higher IGF-I
doses did not further increase 35S-sulfate incorporation.
The increase in 35S-sulfate incorporation, induced by EMF
exposure alone, or in combination with IGF-I, was not
modiﬁed by the presence of serum in the culture medium.
EFFECTS OF EMF EXPOSURE AND IGF-I ON MEDIUM PG
RELEASE OF CARTILAGE EXPLANTS
When we analyzed medium PG release in cartilage
explants, the results did not differ in the absence and in the
presence of 10% FBS in the culture medium. In Fig. 3 we
report the data obtained in unexposed and EMF-exposed
explants treated with increasing doses of IGF-I in the
presence of 10% FBS. EMF exposure and IGF-I treatment
alone or in combination did not signiﬁcantly affect medium
PG release following 24 h treatment, with respect to
controls.
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Fig. 2. Effects of IGF-I and EMF on PG synthesis. Bovine cartilage
explants, cultured in 10% FBS, were treated for 24 h with
increasing doses of IGF-I (1, 5, 10, 50, 100 ng/ml) in the absence
(,) or presence ( ) of EMF. All data are expressed as
meansG S.D. Percentage changes relative to control (explants
cultured in the absence of both EMF exposure and IGF-I) are
shown. Differences were considered signiﬁcant at P% 0.05.
( indicates statistical signiﬁcance vs control. * indicates statistical
signiﬁcance vs the same dose of IGF-I without EMF exposure.
# indicates statistical signiﬁcance vs the previous dose of IGF-I.
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Fig. 3. Effects of IGF-I and EMF on medium PG release. Bovine
cartilage explants, cultured in 10% FBS, were treated for 24 h with
increasing doses of IGF-I (1, 5, 10, 50, 100 ng/ml) in the absence
(,) or presence ( ) of EMF. All data are expressed as
meansG S.D. Differences were considered signiﬁcant at P% 0.05.CHARACTERIZATION OF THE CHONDROCYTE PHENOTYPE IN
MONOLAYERS
It is known that chondrocytes, cultured in monolayer,
show phenotypic instability and can dedifferentiate towards
the ﬁbroblast phenotype, by assuming a ﬂattened morphol-
ogy and shifting from the synthesis of type II to type I
collagen34. Under our experimental conditions, most chon-
drocytes did not diffusely spread and maintain their typical
round morphology. Furthermore, when analyzed by immu-
nohistochemistry, cells stained positive for type II collagen,
a primary marker of the chondrocytic phenotype, and
resulted negative for type I collagen, which is expressed
in dedifferentiated chondrocytes (Fig. 4). Negative controls,
obtained without primary antibodies, did not show any
staining.
EFFECTS OF EMF EXPOSURE AND IGF-I ON PG SYNTHESIS OF
CHONDROCYTE MONOLAYERS
Results in chondrocyte monolayers signiﬁcantly differed
from those obtained in cartilage explants both for respon-
siveness to IGF-I treatment and for responsiveness to EMF
Fig. 4. Immunohistochemistry for type II (A) and type I (B) collagen
of bovine chondrocytes cultured in monolayers. Nuclei were
counterstained by hematoxylin (magniﬁcation 80!).
797Osteoarthritis and Cartilage Vol. 12, No. 10exposure. In the absence of serum (Fig. 5), IGF-I induced
higher increases in 35S-sulfate incorporation than in
cartilage explants maintained in the same culture conditions
and the dose-dependent effect resulted was more evident.
The IGF-I-induced stimulation in 35S-sulfate incorporation
was observed also at doses lower than 10 ng/ml, ranging
from 49% at 1 ng/ml to 133% at 100 ng/ml, over controls.
Similarly to what was observed in cartilage explants, control
monolayers cultured in the presence of serum (Fig. 6)
showed a higher level of 35S-sulfate incorporation than
monolayers cultured in the absence of serum. Like in
cartilage explants, also in monolayers, in the presence
of 10% FBS, IGF-I induced a signiﬁcant increase in
35S-sulfate incorporation only from the dose of 10 ng/ml
and the IGF-I-induced increases resulted lower than in
monolayers cultured in the absence of serum at all the
doses of IGF-I. In chondrocyte monolayers, EMF did not
modify 35S-sulfate incorporation at all the experimental
conditions investigated, independently of the presence of
serum or IGF-I in the culture medium.
EFFECTS OF EMF EXPOSURE AND IGF-I ON 3H-THYMIDINE
INCORPORATION
The effects of EMF exposure and IGF-I treatment on
3H-thymidine incorporation are shown in Fig. 7. As maximal
effects on PG synthesis were observed at 100 ng/ml, this
dose of IGF-I was investigated. In chondrocyte monolayers,
in the absence of serum, EMF alone or in combination with
IGF-I did not modify 3H-thymidine incorporation. In this
experimental condition IGF-I induced a 70% increase over
controls. In the presence of 10% FBS, EMF exposure alone
induced a 31% increase in 3H-thymidine incorporation, and
this effect was additive to the IGF-I-induced increase (21%
over controls). In cartilage explants, EMF did not modify
3H-thymidine incorporation at all the experimental con-
ditions investigated. IGF-I induced 25% and 18% increases
in the absence and in the presence of 10% FBS,
respectively.
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Fig. 5. Effects of IGF-I and EMF on PG synthesis. Chondrocyte
monolayers, cultured in 0% FBS, were treated for 24 h with
increasing doses of IGF-I (1, 5, 10, 50, 100 ng/ml) in the absence
(,) or presence ( ) of EMF. All data are expressed as
meansG S.D. Percentage changes relative to control (chondrocyte
monolayers cultured in the absence of both EMF exposure and
IGF-I) are shown. Differences were considered signiﬁcant at
P% 0.05. ( indicates statistical signiﬁcance vs control. # indicates
statistical signiﬁcance vs the previous dose of IGF-I.Discussion
Clinical35e37 and animal38 studies suggest the possibility
that EMF exposure might be useful for the treatment of OA.
Furthermore, in vitro and in vivo, EMF has shown the ability
to promote cartilage matrix synthesis19e22,24. Analogously,
IGF-I stimulates cartilage matrix synthesis and rep-
air8e14,39,40. Therefore, as EMF and IGF-I appear, re-
spectively, as an important biophysical and biochemical
regulator of articular cartilage metabolism, in this study we
aimed to elucidate the interaction, if existing, between these
two stimuli in the regulation of articular cartilage synthetic
activities.
The results obtained by analyzing the effects of both EMF
and IGF-I in bovine cartilage explants show that each
stimulus alone signiﬁcantly stimulated PG synthesis, in
agreement with previous studies9e11,14,24. By comparing
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Fig. 6. Effects of IGF-I and EMF on PG synthesis. Chondrocyte
monolayers, cultured in 10% FBS, were treated for 24 h with
increasing doses of IGF-I (1, 5, 10, 50, 100 ng/ml) in the absence
(,) or presence ( ) of EMF. All data are expressed as
meansG S.D. Percentage changes relative to control (chondrocyte
monolayers cultured in the absence of both EMF exposure and
IGF-I) are shown. Differences were considered signiﬁcant at
P% 0.05. ( indicates statistical signiﬁcance vs control.
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Fig. 7. Effects of IGF-I and EMF on 3H-thymidine incorporation.
Chondrocyte monolayers and cartilage explants, cultured in 0%
and 10% FBS, were treated for 24 h as follows: 0 ng/ml IGF-I in the
absence of EMF (control) (,); 0 ng/ml IGF-I in the presence of
EMF ( ); 100 ng/ml IGF-I in the absence of EMF ( ); 100 ng/ml
IGF-I in the presence of EMF ( ). All values have been normalized
to corresponding control values (100%). Differences were consid-
ered signiﬁcant at P% 0.05. * indicates statistical signiﬁcance vs
control. ( indicates statistical signiﬁcance vs IGF-I.
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it appears that serum stimulated PG synthesis by itself. As it
is known that IGF-I is present in serum, this effect was
probably mediated, at least in part, by the serum IGF-I
endogenous content11,41. In the presence of serum, the
IGF-I-induced increase in PG synthesis resulted lower than
in explants cultured in medium alone. In fact, at the highest
dose of IGF-I used, PG synthesis stimulation reached only
25% over controls, instead of the 45% increase observed in
the absence of serum. This might be due to an inhibitory
effect exerted by the IGF-binding proteins (IGFBPs)
contained in serum42. On the other hand, the different
percentage of IGF-I-induced PG synthesis increase might
be related to the different synthetic levels of control explants
cultured in the absence and in the presence of serum.
Conversely, the EMF-induced stimulation on PG synthesis
was not dependent on the presence of serum in the culture
medium. This result does not agree with the EMF
stimulation on cell proliferation, observed in chondrocyte
monolayers, as it depends on the presence of serum,
according to a previous study23. In cartilage explants, when
we analyzed the combined effect of EMF and IGF-I we
observed that EMF exposure is able to increase the IGF-I
activity at all the experimental conditions investigated. More
speciﬁcally, whatever the dose of IGF-I, the anabolic effect
of EMF and IGF-I on PG synthesis resulted additive,
suggesting that EMF exposure does not act by increasing
chondrocyte sensitivity to IGF-I. Rather, this result indicates
that the biochemical and the biophysical stimuli act, at least
partly, by different action mechanisms. Our data reﬂect
those obtained by Bonassar et al.14 in the same exper-
imental model, investigating the effects of dynamic com-
pression in the presence of IGF-I, and indicate that these
different physical stimuli may induce similar chondrocyte
activities.
As it is known that transient anabolic activities in cartilage
may represent a reactivity of the tissue to PG loss from
ECM2,43, we also analyzed the medium PG release which
did not differ from control cartilage explants, at all the
experimental conditions tested. These results appear to
conﬁrm that both EMF exposure24 and IGF-I8,44,45 also
when applied in combination, do not induce increased PG
loss from the tissue and/or the activation of catabolic
events. Thus, the effects we have observed on PG
synthesis may be considered the result of a direct
stimulation on PG synthesis anabolic pathway and not
a secondary reaction to an increased PG release.
Data obtained in chondrocyte monolayers only partially
conﬁrmed those obtained in cartilage explants. Also in
monolayer cultures, both serum and IGF-I stimulated PG
synthesis. Differently, in chondrocyte monolayers cultured
in the absence of serum, IGF-I induced a signiﬁcant
increase on PG synthesis also at doses which were
ineffective in cartilage explants and the IGF-I-induced
increases resulted higher than in cartilage explants at all
the doses of IGF-I investigated. The higher responsiveness
to IGF-I in monolayers may reﬂect limitations in the ability of
IGF-I to diffuse into the ECM. Moreover, this result might be
due to the ECM endogenous content in IGFBPs, which can
play an inhibitory role on IGF-I activity46. Indeed, our results
show that under our experimental conditions, chondrocytes
in monolayer remained responsive to the biochemical
exogenous stimuli. On the contrary, with regard to EMF
stimulation, data obtained in chondrocyte monolayers
signiﬁcantly differed from those obtained in cartilage
explants. In fact, in this experimental system, independently
of the presence of serum in the culture medium, the effectsof the biophysical stimuli, alone or in combination with IGF-I
treatment, on PG synthesis were completely lost.
In our monolayer cultures, most chondrocytes maintained
their typical round morphology and the expression of
collagen type II, whereas they did not show the presence
of collagen type I. Therefore, these results seem to indicate
that no deﬁnite sign of chondrocyte dedifferentiation34 is
responsible for the loss of EMF responsiveness in mono-
layers. We cannot exclude, however, that initial dediffer-
entiative events might be involved. In order to clarify
whether the loss of any EMF effect on PG synthesis might
be due to the EMF insensitivity of bovine chondrocytes
cultured in monolayer and to further investigate the
chondrocyte responsiveness to EMF exposure and IGF-I
treatment in the two experimental systems, we also
analyzed cell proliferation. Our results showed that EMF
increased 3H-thymidine incorporation in chondrocyte mono-
layers only when serum was present in the culture medium,
as previously reported on human chondrocytes23, and that
this effect was additive to the IGF-I-induced increase. On
the contrary, EMF did not modify 3H-thymidine incorporation
in cartilage explants, at all the experimental conditions
tested. Altogether these data indicate that bovine chon-
drocytes cultured in monolayer maintained EMF sensitivity,
although PG synthesis could not be affected. Further, the
observed EMF effect on PG synthesis in cartilage explants
can be considered a speciﬁc modulation of the chondrocyte
activity in this experimental model. According to previous
studies44,47, IGF-I could stimulate cell proliferation in both
experimental systems, and similarly to what was observed
on PG synthesis, maximal effects were observed in
monolayers cultured in the absence of serum.
To our knowledge, this is the ﬁrst report to compare the
behaviour of chondrocytes to EMF in different experimental
models. On the other hand, differences in the responsive-
ness of chondrocytes in different experimental models have
already been previously reported with regard to other
biophysical forces such as mechanical strain48e50. More-
over, it has been reported that the biosynthetic response to
mechanical loading of chondrocytes cultured in agarose is
dependent on the formation of ECM components51.
Similarly, the results, obtained in the two experimental
systems used in this study, suggest that the EMF
stimulation on PG synthesis is dependent on the presence
of the native ECM and the associated interactions between
the chondrocyte and ECM components, which are main-
tained in tissue explants. Therefore, factors such as
chondrocyte adhesion status, expression and binding of
surface chondrocyte molecules such as integrins to matrix
components, which are known to modulate chondrocyte
activity and responsiveness to growth factors52, seem to
play an essential role in mediating the EMF effects on
articular cartilage. Further, our results strongly support the
importance of the experimental model in analyzing the EMF
effects, showing that cartilage explants represent a better
model to investigate the effects of EMF exposure on
cartilage ECM synthesis. It should be also noted that the
experiments of this study were performed on cartilage from
young animals. The effects may be more evident in
cartilage from older animals, as age differences in response
to physical forces have been reported by others53.
In conclusion, the ﬁndings of this study suggest two main
conclusions concerning the effects of EMF exposure on
articular cartilage metabolism. The ﬁrst is that EMF can act
in concert with the major anabolic growth factor for cartilage
to stimulate the synthesis of essential cartilage matrix
components. The second is that the maintenance of the
799Osteoarthritis and Cartilage Vol. 12, No. 10native cellematrix interactions seems to be fundamental in
driving the EMF-induced stimulation of PG synthesis. From
a clinical point of view, our data suggest that in vivo the
combination of both EMF exposure and IGF may exert
a more chondroprotective effect than either treatment alone
on articular cartilage.
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